CanBrs Therapeutics
Nanomedicine drug delivery for breast cancer
CanBrs Therapeutics
About
CanBrS Therapeutics develops nanoparticle-based, antibody-targeted drug-delivery systems for breast cancer treatment, aiming to concentrate chemotherapy at the tumour site and reduce the systemic side effects of conventional cancer therapy.
Startup Information
Company Name
CanBrS Therapeutics Private Limited
Location
Chennai
Incorporated Year
2022
Incubated With
IITM Incubation Cell
Sector
Healthcare & Biotech
Focus Areas
Founder Details
Founder
Balu Ranganathan
Designation
Co-Founder
Bio
Nanomedicine and drug-delivery researcher with widely cited work on antibody-targeted breast-cancer nanoparticles; Co-Founder of CanBrS Therapeutics, developing targeted chemotherapy delivery systems.